Feilin A. Cao

174 Changhai Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial.

Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial.

Journal: eLife

Published: April 03, 2025

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.

Journal: Biomarkers in medicine

Published: March 26, 2025

Hsa_circ_0002346 inhibits proliferation, invasion, and migration of breast cancer cells and promotes apoptosis: A novel potential biomarker for breast cancer.

Hsa_circ_0002346 inhibits proliferation, invasion, and migration of breast cancer cells and promotes apoptosis: A novel potential biomarker for breast cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 17, 2025

ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer.

ACE-Breast-02: a randomized phase III trial of ARX788 versus lapatinib plus capecitabine for HER2-positive advanced breast cancer.

Journal: Signal transduction and targeted therapy

Published: September 01, 2024

EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer.

EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer.

Journal: Frontiers in oncology

Published: May 15, 2024

A Multicenter, Randomized, Controlled Study of the Breast Biopsy and Circumferential Excision System for Breast Lesions.

A Multicenter, Randomized, Controlled Study of the Breast Biopsy and Circumferential Excision System for Breast Lesions.

Journal: Clinical breast cancer

Published: November 04, 2022

A prospective cohort study on the clinical value of pelvic peritoneal reconstruction in laparoscopic anterior resection for middle and low rectal cancer

A prospective cohort study on the clinical value of pelvic peritoneal reconstruction in laparoscopic anterior resection for middle and low rectal cancer

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: April 23, 2022

Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine.

Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine.

Journal: Frontiers in cell and developmental biology

Published: July 21, 2021

Proteomics provides individualized options of precision medicine for patients with gastric cancer.

Proteomics provides individualized options of precision medicine for patients with gastric cancer.

Journal: Science China. Life sciences

Published: March 25, 2021

Low-Grade Adenosquamous Carcinoma of the Axilla of Breast Origin in a Male: A Case Report and Literature Review.

Low-Grade Adenosquamous Carcinoma of the Axilla of Breast Origin in a Male: A Case Report and Literature Review.

Journal: Frontiers in oncology

Published: April 23, 2020

CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.

CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.

Journal: Molecular medicine reports

Published: September 27, 2019

Direct binding of microRNA-21 pre-element with Regorafenib: An alternative mechanism for anti-colorectal cancer chemotherapy?

Direct binding of microRNA-21 pre-element with Regorafenib: An alternative mechanism for anti-colorectal cancer chemotherapy?

Journal: Journal of molecular graphics & modelling

Published: January 01, 2017

Showing 1-12 of 34

Last Updated: 09/26/2026